UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition Post published:January 27, 2021 Post category:Analysis/News
North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? Post published:January 21, 2021 Post category:Analysis/News
First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK) Post published:December 28, 2020 Post category:Analysis/News
Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases Post published:December 19, 2020 Post category:News
Canada to Consider Allowing Psychedelic-Assisted Therapy under Special Access Program Amendment Post published:December 12, 2020 Post category:Analysis/News
UK Regulators Approve World’s First DMT for Depression Clinical Trial Post published:December 10, 2020 Post category:News
Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD Post published:November 23, 2020 Post category:News
BBC Two Programme to Follow Psychedelics vs. Antidepressants Trial Post published:November 22, 2020 Post category:News
Psilocybin for Depression Study Approved and Funded by German Government Post published:November 19, 2020 Post category:Clinical Trials/News
First Non-Palliative Canadian Granted Access To Psilocybin Therapy Post published:November 17, 2020 Post category:News